Trial record 1 of 1 for:
NCT06148636
A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06148636 |
|
Recruitment Status :
Active, not recruiting
First Posted : November 28, 2023
Last Update Posted : April 26, 2024
|
Sponsor:
David Bushnell
Collaborators:
Holden Comprehensive Cancer Center
National Cancer Institute (NCI)
Perspective Therapeutics
Information provided by (Responsible Party):
David Bushnell, University of Iowa
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | November 20, 2026 |
| Estimated Study Completion Date : | November 20, 2027 |